Osteoarthritis Cartilage

• 

  Publication Venue For

  • Immune cell profiling in the joint following human and murine articular fracture..  29:915-923. 2021
  • Blood in the joint: effects of hemarthrosis on meniscus health and repair techniques..  29:471-479. 2021
  • Cost-effectiveness of physical activity and exercise therapy programs for knee osteoarthritis: making the case for health plan coverage..  28:719-720. 2020
  • Anti-inflammatory effects of naproxen sodium on human osteoarthritis synovial fluid immune cells..  28:639-645. 2020
  • Intra-articular depletion of macrophages increases acute synovitis and alters macrophage polarity in the injured mouse knee..  28:626-638. 2020
  • Development of a core capability framework for qualified health professionals to optimise care for people with osteoarthritis: an OARSI initiative..  28:154-166. 2020
  • Infrapatellar fat pad abnormalities are associated with a higher inflammatory synovial fluid cytokine profile in young adults following ACL tear..  28:82-91. 2020
  • OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis..  27:1578-1589. 2019
  • Ninety-day and one-year healthcare utilization and costs after knee arthroplasty..  27:1462-1469. 2019
  • Priorities for the effective implementation of osteoarthritis management programs: an OARSI international consensus exercise..  27:1270-1279. 2019
  • Model-based pain and function outcome trajectory types for patients undergoing knee arthroplasty: a secondary analysis from a randomized clinical trial..  27:878-884. 2019
  • Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs..  27:571-579. 2019
  • Osteoarthritis year in review 2018: mechanics..  27:392-400. 2019
  • Towards prevention of post-traumatic osteoarthritis: report from an international expert working group on considerations for the design and conduct of interventional studies following acute knee injury..  27:23-33. 2019
  • Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial..  26:1658-1665. 2018
  • Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project..  26:1257-1261. 2018
  • Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial..  26:631-640. 2018
  • Physical therapy vs internet-based exercise training for patients with knee osteoarthritis: results of a randomized controlled trial..  26:383-396. 2018
  • Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain..  25:1420-1427. 2017
  • Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA..  25:858-865. 2017
  • Reply to Stausholm et al.'s letter to the editor regarding our published study entitled, "Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis"..  25:e11-e14. 2017
  • Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future..  24:2013-2021. 2016
  • Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation..  24:1769-1775. 2016
  • Clinical algorithms to aid osteoarthritis guideline dissemination..  24:1487-1499. 2016
  • Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation..  24:1528-1534. 2016
  • Advances in combining gene therapy with cell and tissue engineering-based approaches to enhance healing of the meniscus..  24:1330-1339. 2016
  • Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance..  24:740-751. 2016
  • Aspartic acid racemization reveals a high turnover state in knee compared with hip osteoarthritic cartilage..  24:374-381. 2016
  • Atlas of radiographic features of osteoarthritis of the ankle and hindfoot..  23:2059-2085. 2015
  • Inflammatory biomarkers in osteoarthritis..  23:1890-1896. 2015
  • Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis..  23:1915-1924. 2015
  • KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study..  23:1674-1684. 2015
  • Non-invasive mouse models of post-traumatic osteoarthritis..  23:1627-1638. 2015
  • Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis..  23:1437-1444. 2015
  • Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use..  23:1233-1241. 2015
  • Radiographic features of hand osteoarthritis in adult Kashin-Beck Disease (KBD): the Yongshou KBD study..  23:868-873. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis..  23:772-786. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of clinical trials of lifestyle diet and exercise interventions for osteoarthritis..  23:787-797. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of implementation trials of interventions for osteoarthritis..  23:826-838. 2015
  • OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis..  23:686-697. 2015
  • Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments..  23:571-580. 2015
  • OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA..  23:550-558. 2015
  • Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study..  23:589-593. 2015
  • Knee osteoarthritis radiographic progression and associations with pain and function prior to knee arthroplasty: a multicenter comparative cohort study..  23:391-396. 2015
  • Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression..  23:70-76. 2015
  • Energy recovery in individuals with knee osteoarthritis..  22:747-755. 2014
  • TSG-6 activity as a novel biomarker of progression in knee osteoarthritis..  22:235-241. 2014
  • Osteoarthritis--a case for personalized health care?.  22:7-16. 2014
  • High prevalence of contralateral ankle abnormalities in association with knee osteoarthritis and malalignment..  21:1693-1699. 2013
  • Imaging biomarker validation and qualification report: sixth OARSI Workshop on Imaging in Osteoarthritis combined with third OA Biomarkers Workshop..  21:939-942. 2013
  • Direct assessment of articular cartilage and underlying subchondral bone reveals a progressive gene expression change in human osteoarthritic knees..  21:450-461. 2013
  • A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis..  21:289-297. 2013
  • Association between serum and urine biomarkers and lumbar spine individual radiographic features: the Johnston County Osteoarthritis Project..  20:1286-1293. 2012
  • Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is different in men and women..  20:603-604. 2012
  • DIO2 modifies inflammatory responses in chondrocytes..  20:440-445. 2012
  • Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254)..  20:271-278. 2012
  • Global metabolic profiling of human osteoarthritic synovium..  20:64-67. 2012
  • Coronal plane ankle alignment, gait, and end-stage ankle osteoarthritis..  19:1338-1342. 2011
  • Summary of the OA biomarkers workshop 2010 - genetics and genomics: new targets in OA..  19:1091-1094. 2011
  • Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee..  19:864-873. 2011
  • Association of knee and ankle osteoarthritis with physical performance..  19:634-638. 2011
  • Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis..  19:668-675. 2011
  • Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis..  19:515-542. 2011
  • Recommendations of the OARSI FDA Osteoarthritis Devices Working Group..  19:509-514. 2011
  • Osteoarthritis year 2010 in review: biochemical markers..  19:346-353. 2011
  • Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes..  19:118-125. 2011
  • Basic methods in histopathology of joint tissues..  18 Suppl 3:S113-S116. 2010
  • Histopathology atlas of animal model systems - overview of guiding principles..  18 Suppl 3:S2-S6. 2010
  • The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig..  18 Suppl 3:S35-S52. 2010
  • Dynamic loading enhances integrative meniscal repair in the presence of interleukin-1..  18:830-838. 2010
  • Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project..  18:825-829. 2010
  • Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies..  18:742-745. 2010
  • Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis..  18:397-405. 2010
  • A comparison of five approaches to measurement of anatomic knee alignment from radiographs..  18:273-277. 2010
  • Racial differences in osteoarthritis pain and function: potential explanatory factors..  18:160-167. 2010
  • Daily pain variations among patients with hand, hip, and knee osteoarthritis..  17:1275-1282. 2009
  • Racial differences in self-reported pain and function among individuals with radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis Project..  17:1132-1136. 2009
  • Subregional femorotibial cartilage morphology in women--comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis..  17:1177-1185. 2009
  • Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA..  17:1056-1064. 2009
  • Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project..  17:772-776. 2009
  • Symptoms of the knee and hip in individuals with and without limb length inequality..  17:596-600. 2009
  • Novel synovial fluid recovery method allows for quantification of a marker of arthritis in mice..  16:1532-1538. 2008
  • Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees..  16:1555-1559. 2008
  • Re: Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62..  16:1585. 2008
  • Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians..  16:1174-1177. 2008
  • PIIANP and HELIXII diurnal variation..  16:1192-1195. 2008
  • Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study..  16:1054-1059. 2008
  • Alpha defensin-1 attenuates surgically induced osteoarthritis in association with promoting M1 to M2 macrophage polarization. 2021
  • TSG-6 - a double-edged sword for osteoarthritis (OA). 2018
  • Biomarkers reflect differences in osteoarthritis phenotypes of the lumbar spine: the Johnston County Osteoarthritis Project. 2017
  • Direct in vivo evidence of activated macrophages in human osteoarthritis. 2016